Glycodelin is a potential novel follow-up biomarker for malignant pleural mesothelioma

por Schneider, Marc A., Muley, Thomas, Kahn, Nicolas C., Warth, Arne, Thomas, Michael, Herth, Felix J.F., Dienemann, Hendrik, Meister, Michael
Publicado en Oncotarget (2016)

Thoracic radiotherapy plus Durvalumab in elderly and/or frail NSCLC stage III patients unfit for chemotherapy - employing optimized (hypofractionated) radiotherapy to foster durval...

por Bozorgmehr, Farastuk, Chung, Inn, Christopoulos, Petros, Krisam, Johannes, Schneider, Marc A., Brückner, Lena, Mueller, Daniel Wilhelm, Thomas, Michael, Rieken, Stefan
Publicado en BMC Cancer (2020)

The Cytoskeletal Adaptor Obscurin-Like 1 Interacts with the Human Papillomavirus 16 (HPV16) Capsid Protein L2 and Is Required for HPV16 Endocytosis

por Wüstenhagen, Elena, Hampe, Laura, Boukhallouk, Fatima, Schneider, Marc A., Spoden, Gilles A., Negwer, Inka, Koynov, Kaloian, Kast, W. Martin, Florin, Luise
Publicado en J Virol (2016)

Pathways regulating the expression of the immunomodulatory protein glycodelin in non-small cell lung cancer

por Weber, Rebecca, Meister, Michael, Muley, Thomas, Thomas, Michael, Sültmann, Holger, Warth, Arne, Winter, Hauke, Herth, Felix J.F., Schneider, Marc A.
Publicado en Int J Oncol (2018)

The Transcription Factors TBX2 and TBX3 Interact with Human Papillomavirus 16 (HPV16) L2 and Repress the Long Control Region of HPVs

por Schneider, Marc A., Scheffer, Konstanze D., Bund, Timo, Boukhallouk, Fatima, Lambert, Carsten, Cotarelo, Cristina, Pflugfelder, Gert O., Florin, Luise, Spoden, Gilles A.
Publicado 2013

Brigatinib versus other second-generation ALK inhibitors as initial treatment of anaplastic lymphoma kinase positive non-small cell lung cancer with deep phenotyping: study protoco...

por Christopoulos, Petros, Bozorgmehr, Farastuk, Brückner, Lena, Chung, Inn, Krisam, Johannes, Schneider, Marc A., Stenzinger, Albrecht, Eickhoff, Regina, Mueller, Daniel W., Thomas, Michael
Publicado en BMC Cancer (2021)

FAM83A and FAM83B as Prognostic Biomarkers and Potential New Therapeutic Targets in NSCLC

por Richtmann, Sarah, Wilkens, Dennis, Warth, Arne, Lasitschka, Felix, Winter, Hauke, Christopoulos, Petros, Herth, Felix J. F., Muley, Thomas, Meister, Michael, Schneider, Marc A.
Publicado en Cancers (Basel) (2019)

AURKA, DLGAP5, TPX2, KIF11 and CKAP5: Five specific mitosis-associated genes correlate with poor prognosis for non-small cell lung cancer patients

por Schneider, Marc A., Christopoulos, Petros, Muley, Thomas, Warth, Arne, Klingmueller, Ursula, Thomas, Michael, Herth, Felix J.F., Dienemann, Hendrik, Mueller, Nikola S., Theis, Fabian, Meister, Michael
Publicado en Int J Oncol (2017)

Blood-sampling collection prior to surgery may have a significant influence upon biomarker concentrations measured

por Kahn, Nicolas, Riedlinger, Julia, Roeßler, Markus, Rabe, Christina, Lindner, Michael, Koch, Ina, Schott-Hildebrand, Sabine, Herth, Felix J, Schneider, Marc A, Meister, Michael, Muley, Thomas R
Publicado en Clin Proteomics (2015)

Epigenetic Inactivation of the Tumor Suppressor IRX1 Occurs Frequently in Lung Adenocarcinoma and Its Silencing Is Associated with Impaired Prognosis

por Küster, Miriam M., Schneider, Marc A., Richter, Antje M., Richtmann, Sarah, Winter, Hauke, Kriegsmann, Mark, Pullamsetti, Soni S., Stiewe, Thorsten, Savai, Rajkumar, Muley, Thomas, Dammann, Reinhard H.
Publicado en Cancers (Basel) (2020)

Impact of Natural or Synthetic Singletons in the Capsid of Human Bocavirus 1 on Particle Infectivity and Immunoreactivity

por Fakhiri, Julia, Linse, Kai-Philipp, Mietzsch, Mario, Xu, Man, Schneider, Marc A., Meister, Michael, Schildgen, Oliver, Schnitzler, Paul, Soderlund-Venermo, Maria, Agbandje-McKenna, Mavis, Grimm, Dirk
Publicado en J Virol (2020)

Comprehensive Dissection of Treatment Patterns and Outcome for Patients With Metastatic Large-Cell Neuroendocrine Lung Carcinoma

por Fisch, David, Bozorgmehr, Farastuk, Kazdal, Daniel, Kuon, Jonas, Klotz, Laura V., Shah, Rajiv, Eichhorn, Florian, Kriegsmann, Mark, Schneider, Marc A., Muley, Thomas, Stenzinger, Albrecht, Bischoff, Helge, Christopoulos, Petros
Publicado en Front Oncol (2021)

Glycodelin as a Serum and Tissue Biomarker for Metastatic and Advanced NSCLC

por Schneider, Marc A., Muley, Thomas, Weber, Rebecca, Wessels, Sabine, Thomas, Michael, Herth, Felix J. F., Kahn, Nicolas C., Eberhardt, Ralf, Winter, Hauke, Heussel, Gudula, Warth, Arne, Herold-Mende, Christel, Meister, Michael
Publicado en Cancers (Basel) (2018)

Novel Chimeric Gene Therapy Vectors Based on Adeno-Associated Virus and Four Different Mammalian Bocaviruses

por Fakhiri, Julia, Schneider, Marc A., Puschhof, Jens, Stanifer, Megan, Schildgen, Verena, Holderbach, Stefan, Voss, Yannik, El Andari, Jihad, Schildgen, Oliver, Boulant, Steeve, Meister, Michael, Clevers, Hans, Yan, Ziying, Qiu, Jianming, Grimm, Dirk
Publicado en Mol Ther Methods Clin Dev (2019)

Fibroblast Growth Factor—14 Acts as Tumor Suppressor in Lung Adenocarcinomas

por Turkowski, Kati, Herzberg, Frederik, Günther, Stefan, Brunn, David, Weigert, Andreas, Meister, Michael, Muley, Thomas, Kriegsmann, Mark, Schneider, Marc A., Winter, Hauke, Thomas, Michael, Grimminger, Friedrich, Seeger, Werner, Savai Pullamsetti, Soni, Savai, Rajkumar
Publicado en Cells (2020)

SARS‐CoV‐2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells

por Lukassen, Soeren, Chua, Robert Lorenz, Trefzer, Timo, Kahn, Nicolas C, Schneider, Marc A, Muley, Thomas, Winter, Hauke, Meister, Michael, Veith, Carmen, Boots, Agnes W, Hennig, Bianca P, Kreuter, Michael, Conrad, Christian, Eils, Roland
Publicado en EMBO J (2020)

DNA methylation profiles of bronchoscopic biopsies for the diagnosis of lung cancer

por Goldmann, Torsten, Schmitt, Bernhard, Müller, Julia, Kröger, Maren, Scheufele, Swetlana, Marwitz, Sebastian, Nitschkowski, Dörte, Schneider, Marc A., Meister, Michael, Muley, Thomas, Thomas, Michael, Kugler, Christian, Rabe, Klaus F., Siebert, Reiner, Reck, Martin, Ammerpohl, Ole
Publicado en Clin Epigenetics (2021)

Germline Genetic Variants of the Renin-Angiotensin System, Hypoxia and Angiogenesis in Non-Small Cell Lung Cancer Progression: Discovery and Validation Studies

por Catarata, Maria Joana, Medeiros, Rui, Oliveira, Maria José, Pêgo, Alice, Frade, João Gonçalo, Martins, Maria Fátima, Robalo Cordeiro, Carlos, Herth, Felix J. F., Thomas, Michael, Kriegsmann, Mark, Meister, Michael, Schneider, Marc A., Muley, Thomas, Ribeiro, Ricardo
Publicado en Cancers (Basel) (2020)

Screening drug effects in patient‐derived cancer cells links organoid responses to genome alterations

por Jabs, Julia, Zickgraf, Franziska M, Park, Jeongbin, Wagner, Steve, Jiang, Xiaoqi, Jechow, Katharina, Kleinheinz, Kortine, Toprak, Umut H, Schneider, Marc A, Meister, Michael, Spaich, Saskia, Sütterlin, Marc, Schlesner, Matthias, Trumpp, Andreas, Sprick, Martin, Eils, Roland, Conrad, Christian
Publicado en Mol Syst Biol (2017)

Novel Liquid Biomarker Panels for A Very Early Response Capturing of NSCLC Therapies in Advanced Stages

por Janke, Florian, Bozorgmehr, Farastuk, Wrenger, Sabine, Dietz, Steffen, Heussel, Claus P., Heussel, Gudula, Silva, Carlos F., Rheinheimer, Stephan, Feisst, Manuel, Thomas, Michael, Golpon, Heiko, Günther, Andreas, Sültmann, Holger, Muley, Thomas, Janciauskiene, Sabina, Meister, Michael, Schneider, Marc A.
Publicado en Cancers (Basel) (2020)